# A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804

> **NCT01589614** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PH-797804
- **DRUG:** PH-797804 + erythromycin

## Key facts

- **NCT ID:** NCT01589614
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01589614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01589614, "A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01589614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*